Related Experiment Video

Updated: Feb 17, 2026

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

2.1K

Autophagy Inhibition in Pancreatic Adenocarcinoma

Brian A Boone1, Herbert J Zeh1, Nathan Bahary2

  • 1Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

Clinical Colorectal Cancer
|December 11, 2017
PubMed

Insights

Targeting autophagy, a cell survival process, offers a promising new strategy to improve pancreatic cancer treatment outcomes. Further research into this mechanism could enhance patient survival and therapeutic effectiveness.

Area of Science:

  • Oncology
  • Cellular Biology
  • Cancer Therapeutics

Background:

  • Pancreatic adenocarcinoma remains a challenging cancer with limited effective treatments.
  • Autophagy, a cellular degradation process, supports cancer cell survival in harsh tumor microenvironments.
  • Targeting autophagy presents a potential therapeutic strategy for pancreatic cancer.

Purpose of the Study:

  • To review the mechanism of autophagy.
  • To examine autophagy's role in pancreatic cancer development.
  • To assess the evidence for targeting autophagy in pancreatic adenocarcinoma treatment.

Main Methods:

  • Literature review of preclinical studies.
  • Analysis of clinical trial data.
  • Exploration of future research directions.

Main Results:

  • Autophagy is a key survival mechanism for pancreatic cancer cells.
  • Preclinical and clinical data suggest targeting autophagy can be beneficial.
  • Several strategies for targeting autophagy are under investigation.

Conclusions:

  • Targeting autophagy is a promising approach to improve pancreatic adenocarcinoma treatment.
  • Further research is needed to optimize autophagy-targeting therapies.
  • Combination strategies involving autophagy inhibitors may enhance patient outcomes.
Keywords:
ApoptosisChloroquineDamage-associated molecular pattern molecule (DAMP)High-mobility group box 1 (HMGB1)Hydroxychloroquine

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.2K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K